FTI
61
-3
HBI
53
-5
GRMN
52
-3
FLR
50
-2
DAL
61
-3
MAR
57
-3
KR
50
-2
TDC
67
-3
V
68
-8
USB
48
-5
O
15
-11
CMA
43
-5
SCHW
37
-3
INTU
54
-3
TAP
51
-2
BWA
44
-2
PNW
55
-2
ABBV
48
-2
TGNA
48
-5
OMC
37
-2
FTI
61
-3
HBI
53
-5
GRMN
52
-3
FLR
50
-2
DAL
61
-3
MAR
57
-3
KR
50
-2
TDC
67
-3
V
68
-8
USB
48
-5
O
15
-11
CMA
43
-5
SCHW
37
-3
INTU
54
-3
TAP
51
-2
BWA
44
-2
PNW
55
-2
ABBV
48
-2
TGNA
48
-5
OMC
37
-2
Financhill
Back

IGC Pharma 10K Form

Sell
39

IGC
IGC Pharma

Last Price:
$0.37
Seasonality Move:
36.4%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive IGC News And Ratings

See the #1 stock for the next 7 days that we like better than IGC

IGC Financial Statistics

Sales & Book Value

Annual Sales: $1.3M
Cash Flow: $-1.1M
Price / Cash Flow: 0
Annual Sales: $0.10
Price / Book: 3.88

Profitability

EPS (TTM): -0.18000
Net Income (TTM): $-12.6M
Gross Margin: $733K
Return on Equity: -137.43%
Return on Assets: -107.19%

IGC Pharma Earnings Forecast

Key IGC Pharma Financial Ratios

  • The Gross Profit Margin over the past 17 years for IGC is 54.50%.
  • The Selling, General & Administrative Expenses for IGC have been equal to 502.45% of Gross Profit Margin.
  • The Research & Development expenses have been 280.52% of Revenue.
  • The Interest Expense is -1.74% of Operating Income.
  • The Net Earning history of IGC is -966.54% of Total Revenues.
  • Per Share Earnings over the last 19 years have been positive in 9 years.

IGC Pharma Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYAM
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: IGC
CUSIP: 45408X
Website: igcinc.us

Debt

Debt-to-Equity Ratio: 0.02
Current Ratio: 1.52
Quick Ratio: 0.58

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

IGC Technical Analysis vs Fundamental Analysis

Sell
39
IGC Pharma (IGC) is a Sell

Is IGC Pharma a Buy or a Sell?

  • IGC Pharma stock is rated a Sell
    The current IGC Pharma [IGC] share price is $0.37. The Score for IGC is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.